SMA 200 společnosti OncoSec Medical Inc
Jaká je hodnota metriky SMA 200 společnosti OncoSec Medical Inc?
Hodnota metriky SMA 200 společnosti OncoSec Medical Inc je $0 +100.00%
Jaká je definice metriky SMA 200?
SMA 200 je průměrná cena akcií z posledních 200 dnů vypočítaná jako nevážený průměr předchozích 200 závěrečných cen.
Simple moving average of 200 days for a stock is an unweighted moving average over the past 200 days. Moving averages will always exhibit a lag and the longer the period used for averaging the greater the lag will be. Because of the large amounts of data considered when calculating a long-term moving average, it takes a considerable amount of movement in the market to cause the moving average to change its course.
Using a moving average to confirm a trend in price is one of the most basic, yet effecting ways of using the indicator. Moving averages take into account what has already happened and a whole range of past events, which makes them such a good technical analysis tool for trend confirmations. Generally, a long-term moving average that is clearly on the upswing is a confirmation of a bullish trend. Conversely, a long-term moving average that is clearly on the downswing is a confirmation of a bearish trend.
SMA 200 společností v sektoru Health Care sektor na NASDAQ ve srovnání se společností OncoSec Medical Inc
Čemu se věnuje společnost OncoSec Medical Inc?
oncosec is a san diego-based biotechnology company pioneering new technologies to stimulate the body’s immune system to target and attack cancer. through our proprietary technology, we hope to deliver safer and more effective cancer treatments that can provide long-term benefits for patients. our technology, immunopulse™, is designed to enhance the local delivery and uptake of dna-based immune-targeting agents, such as il-12. clinical trials of immunopulse™ il-12 demonstrated a favorable safety profile and evidence of anti-tumor activity in the treatment of various skin cancers as well as the potential to initiate a systemic immune response. our lead program, immunopulse™ il-12, is currently in phase ii development for several indications, including metastatic melanoma, squamous cell carcinoma of the head and neck, and triple-negative breast cancer. to date, study results have laid the groundwork for the expansion into new dna-encoded therapeutic candidates and tumor indications. we ar
Firmy s metrikou sma 200 podobnou společnosti OncoSec Medical Inc
- Hodnota metriky SMA 200 společnosti OncoSec Medical Inc je $0 +100.00%
- Hodnota metriky SMA 200 společnosti EVmo Inc je $0 +96.08%
- Hodnota metriky SMA 200 společnosti Predictive Technology je $0 +26.47%
- Hodnota metriky SMA 200 společnosti Kaleido Biosciences Inc je $0 +25.93%
- Hodnota metriky SMA 200 společnosti Identillect Technologies je CAD$0 +98.52%
- Hodnota metriky SMA 200 společnosti Atlas je $0 +79.84%
- Hodnota metriky SMA 200 společnosti Cycliq je AUD$0 +98.35%